254 related articles for article (PubMed ID: 23232108)
1. Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
Zhao L; He LR; Xi M; Cai MY; Shen JX; Li QQ; Liao YJ; Qian D; Feng ZZ; Zeng YX; Xie D; Liu MZ
J Transl Med; 2012 Dec; 10():249. PubMed ID: 23232108
[TBL] [Abstract][Full Text] [Related]
2. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
[TBL] [Abstract][Full Text] [Related]
3. Nimotuzumab, an EGFR‑targeted antibody, promotes radiosensitivity of recurrent esophageal squamous cell carcinoma.
Yu Y; Guan H; Jiang L; Li X; Xing L; Sun X
Int J Oncol; 2020 Apr; 56(4):945-956. PubMed ID: 32319582
[TBL] [Abstract][Full Text] [Related]
4. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
5. Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma.
Luo LL; Zhao L; Wang YX; Tian XP; Xi M; Shen JX; He LR; Li QQ; Liu SL; Zhang P; Xie D; Liu MZ
Sci Rep; 2015 Dec; 5():17336. PubMed ID: 26670461
[TBL] [Abstract][Full Text] [Related]
6. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
[TBL] [Abstract][Full Text] [Related]
7. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
8. Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.
Zhang G; Zhang Q; Zhang Q; Yin L; Li S; Cheng K; Zhang Y; Xu H; Wu W
J Cancer Res Clin Oncol; 2010 Apr; 136(4):587-94. PubMed ID: 19823871
[TBL] [Abstract][Full Text] [Related]
9. Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma.
Luo LL; Zhao L; Xi M; He LR; Shen JX; Li QQ; Liu SL; Zhang P; Xie D; Liu MZ
Chin J Cancer; 2015 Sep; 34(11):514-21. PubMed ID: 26370590
[TBL] [Abstract][Full Text] [Related]
10. Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma.
Song H; Pan B; Yi J; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):529-41. PubMed ID: 24625442
[TBL] [Abstract][Full Text] [Related]
11. Nimotuzumab enhances the radiosensitivity of cancer cells in vitro by inhibiting radiation-induced DNA damage repair.
Qu YY; Hu SL; Xu XY; Wang RZ; Yu HY; Xu JY; Chen L; Dong GL
PLoS One; 2013; 8(8):e70727. PubMed ID: 23976954
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
13. Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
Zhang W; Pang Q; Zhang X; Yan C; Wang Q; Yang J; Yu S; Liu X; Pan Y; Yuan Z; Wang P; Xiao Z
Cancer Sci; 2017 Apr; 108(4):590-597. PubMed ID: 28192623
[TBL] [Abstract][Full Text] [Related]
14. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
15. Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.
Song L; Gong H; Lin C; Wang C; Liu L; Wu J; Li M; Li J
Gastroenterology; 2012 Oct; 143(4):995-1005.e12. PubMed ID: 22732732
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status.
Akashi Y; Okamoto I; Iwasa T; Yoshida T; Suzuki M; Hatashita E; Yamada Y; Satoh T; Fukuoka M; Ono K; Nakagawa K
Br J Cancer; 2008 Feb; 98(4):749-55. PubMed ID: 18253126
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
18. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
[TBL] [Abstract][Full Text] [Related]
20. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
